XML 53 R16.htm IDEA: XBRL DOCUMENT
v3.20.1

Accrued Expenses | 12 Months Ended
--- | ---
Dec. 31, 2019
Payables And Accruals [Abstract] |
Accrued Expenses |
(8) | Accrued Expenses
Current accrued expenses include the following:
(in thousands) |  | December 31, 2019 |  |  | December 31, 2018 |
Clinical trial expenses |  | $ | 2,497 |  |  | $ | 4,530 |
Compensation, excluding taxes |  |  | 3,525 |  |  |  | 1,785 |
Professional fees |  |  | 263 |  |  |  | 190 |
Short-term portion of lease restructuring |  |  | - |  |  |  | 184 |
Other1 |  |  | 662 |  |  |  | 1,275 |
Total accrued expenses |  | $ | 6,947 |  |  | $ | 7,964 |
1Other consists of various accrued expenses, with no individual item accounting for more than 5% of current liabilities at December 31, 2019 and 2018.

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration